Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimada

Showing results (181-190 of 295) with videos related to

Pageof 30
Sort By:
Cancer Medicine|January 24, 2013
Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studiesKenichi Sugihara, Atsushi Ohtsu, Yasuhiro Shimada, et al.
Japanese Journal of Clinical Oncology|July 12, 2012
Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intakeSatoru Iwasa, Masahiro Goto, Hirofumi Yasui, et al.
Journal of Oncology Practice|September 3, 2011
Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trialChiharu Tanai, Takako Eguchi Nakajima, Kengo Nagashima, et al.
International Journal of Clinical Oncology|September 27, 2012
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patientsKohei Ogawa, Takao Ueno, Ken Kato, et al.
Computer Methods in Biomechanics and Biomedical Engineering|July 17, 2010
Visualisation of hypopharyngeal cavities and vocal-tract acoustic modellingKiyoshi Honda, Tatsuya Kitamura, Hironori Takemoto, et al.
The British Journal of Radiology|June 8, 2017
Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancerKenta Sui, Takehiro Okabayashi, Yasuo Shima, et al.
Oncotarget|December 31, 2015
Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancerNaoki Takahashi, Koh Furuta, Hirokazu Taniguchi, et al.
Japanese Journal of Clinical Oncology|May 31, 2022
A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trialMasayuki Ohue, Satoru Iwasa, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|May 11, 2006
Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancerYasuhide Yamada, Atsushi Ohtsu, Narikazu Boku, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed studyRyo Inada, Takeshi Nagasaka, Mototsugu Shimokawa, et al.
Pageof 30

Showing results (181-190 of 295) with videos related to

Sort By:
Pageof 30
Cancer Medicine|January 24, 2013
Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studiesKenichi Sugihara, Atsushi Ohtsu, Yasuhiro Shimada, et al.
Japanese Journal of Clinical Oncology|July 12, 2012
Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intakeSatoru Iwasa, Masahiro Goto, Hirofumi Yasui, et al.
Journal of Oncology Practice|September 3, 2011
Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trialChiharu Tanai, Takako Eguchi Nakajima, Kengo Nagashima, et al.
International Journal of Clinical Oncology|September 27, 2012
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patientsKohei Ogawa, Takao Ueno, Ken Kato, et al.
Computer Methods in Biomechanics and Biomedical Engineering|July 17, 2010
Visualisation of hypopharyngeal cavities and vocal-tract acoustic modellingKiyoshi Honda, Tatsuya Kitamura, Hironori Takemoto, et al.
The British Journal of Radiology|June 8, 2017
Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancerKenta Sui, Takehiro Okabayashi, Yasuo Shima, et al.
Oncotarget|December 31, 2015
Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancerNaoki Takahashi, Koh Furuta, Hirokazu Taniguchi, et al.
Japanese Journal of Clinical Oncology|May 31, 2022
A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trialMasayuki Ohue, Satoru Iwasa, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|May 11, 2006
Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancerYasuhide Yamada, Atsushi Ohtsu, Narikazu Boku, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed studyRyo Inada, Takeshi Nagasaka, Mototsugu Shimokawa, et al.
Pageof 30